Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease - Takeaways - MDSpire

Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease

  • By

  • Phillip S. Cheng

  • Jonathan A. Wheeler

  • Aaron T. Walsh

  • Chance R. Alvarado

  • Kan N. Hor

  • Andrew H. Tran

  • July 4, 2026

  • 0 min

Share

  • 1

    Dyslipidemia in childhood increases the risk of atherosclerosis and cardiovascular disease in adulthood.

  • 2

    The American Academy of Pediatrics recommends lipid screening for children at ages 9-11 and 17-21, but adherence is low.

  • 3

    Children with congenital heart disease have a higher lifetime risk of cardiovascular disease compared to those without.

  • 4

    Only 18-31% of children with congenital heart disease underwent lipid screening, depending on the cardiac diagnosis.

  • 5

    The study aims to assess lipid screening rates and dyslipidemia prevalence among children with various congenital heart defects.

Original Source(s)

Related Content